長佳智能股票上櫃前將競拍
(Permission has been given by Money Weekly to publish this excerpt)
【理財周刊授權節錄】
On November 3, 2022, Ever Fortune AI (6841) received approval to be listed on the over-the-counter market, and went on to hold a pre-IPO performance conference on February 1 of this year.
在去(2022)年11月3日通過股票上櫃案的長佳智能(6841)，2月1日舉辦上櫃前業績發表會，
approval(n.)認可、許可receive the green light經許可、獲准list(v.)列舉；列於over the counter (OTC) market上櫃市場
Chairperson Chen Ming-fong says that digital medicine is the trend of the future, and authoritative institutions on the subject predict that the scale of the global healthcare AI market is poised to grow by nearly 20-fold in seven years. Things are looking good.
董事長陳明豐董事長表示，數位醫療是未來趨勢，且權威機構預估全球醫療保健AI的市場規模，在7年內將會成長將近20倍，前景看好。
authoritative(adj.)權威性authority(n.)權威authority on the subject該領域權威institution(n.)機構 (=institute)be poised to…準備好要～fold(n.)倍Things are looking good.前景看好、目前情況不錯
Ever Fortune AI is Taiwan’s first OTC-traded company that positions itself as a medical AI company.
長佳智能是國內第一家定位於醫療人工智能的上櫃公司，
position oneself as… 把自己定位為～
Its shareholders include Trend Micro, Quanta, HIWIN MIKROSYSTEM, HIWIN, Centerlab, Yuanta, AnnJi, Shang-ho, etc., and its Chairperson and General Manager is the Former Superintendent of National Taiwan University Hospital, Chen Ming-fong.
股東成員包含趨勢科技、廣達、大銀、上銀、晟德、元大、安基、尚禾等，董事長兼總經理為前台大醫院陳明豐院長。
shareholder(n.)股東、持股人chairperson(n.)董事長(另有chairman與chairwoman)general(adj.)一般、總superintendent(n.)主管、負責人
Chen Ming-fong expresses joy at the fact that Taiwan’s industries, government, academic community, and research facilities are all working towards the common goal of digital medicine.
陳明豐表示，近幾年台灣的產、官、學、研，共同朝向數位醫療的方向邁進，這值得喝采。
work towards致力於
Medical AI is the core of digital medicine, an incredibly large piece of the market pie that was reported to have been worth $6.7 billion in 2020 and $10.4 billion in 2021 by globally renowned market research institute Grand View Research in 2021.
其中，醫療AI是數位醫療的核心之一，這塊餅非常的大，據全球知名的權威市場評估機構Grand View Research2021年的報導，全球醫療保健AI市場規模2020年為67億美元，2021年為104億美元，預估2022年起至2028年，複合年增長率為41.8%，
core(n.)核心、最重要的部分incredibly(adv.)極其incredible(adj.)難以置信的、不可思議renowned(adj.)著名的、享盛名的renown(n.)盛名grand(n.)宏大、宏偉
Its market value is predicted to reach $120.2 billion by 2028, registering a compound annual growth rate (CAGR) of 41.8% for the period from 2022 to 2028, which means that the medical AI market will have grown to 20 times its original size in seven years.
到2028年市場規模將達到1,202億美元，也就是說，醫療AI的市場在七年內將會成長將近20倍。
That’s an opportunity for Taiwan: the relevant public and private institutes may create another “Silicon Shield.”
這是台灣的機會，台灣相關公民營機構可以共同努力打造另一個護國群山。
relevant(adj.)相關的relevance(n.)相關、相關度silicon(n.)矽shield(n.)護盾、盾牌
Masterlink Securities Investment Advisory’s report points out that Ever Fortune AI uses AI as a tool to create solutions for various fields in biotech.
元富投顧研究報告指出，長佳智能以人工智慧為工具，打造各生醫領域之解決方案，
biotech (biotechnology的簡寫)(n.)生物科技biomedicine(n.)生物醫學biomedical(adj.)生醫的medical(adj.)醫療的
Ever Fortune AI’s R&D team includes solution architects, biomedical informatics engineers, senior clinical physicians, data scientists and experts from various other fields.
長佳智能研發團隊有「解決方案架構師」、「生醫資訊工程師」、「資深臨床醫師」、「資料科學家」等領域專業人員，
R&D(n.)研發 (research and development)informatics資訊學senior(adj.)級別高的、經驗老到的、資深的clinical(adj.)門診的、臨床的data(n.)數據 (集合名詞)datum(n.)單一數據
It also has a professional team of medical consultants, which includes doctors from various specializations, that can develop solutions to directly address clinical needs and increase the efficiency and accuracy of medical policies.
並聘有專業的醫療顧問團隊，包含各科部醫師，直接面對臨床需求開發解決方案，提升醫療決策的效率與準確度。
professional(adj.)專業的consultant(n.)顧問specialization(n.)專業領域need(n.)需求want(v.)(n.)想要；慾望demand(n.)(市場)需求efficiency(n.)效率accuracy(n.)準確度policy(n.)政策、方針